Mizuho analyst Christopher Parkinson keeps Buy rating on PPG Industries, Inc. (NYSE:PPG), raising the price target to $152 from $151. The analyst notes…
Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced new clinical data demonstrating